Search
Neogen Corp
NEOGAdd to Watchlist
12.040USD
+0.510+4.42%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.63BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Neogen Corp is 7.20, ranking 149 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 7.25, with a high of 10.00 and a low of 6.00.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
11.805
Target Price
-1.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Neogen Corp
NEOG
5
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Neogen Corp's expected revenue for the next quarter?
Neogen Corp's expected revenue is 206.85M.
What is Neogen Corp's price target?
Analysts forecast that Neogen Corp's price target is USD 7.25, with the highest forecast at USD 10.00 and the lowest forecast at USD 6.00.
How have Neogen CorpNEOG's recent earnings per share performed?
The market expectation was USD -0.05, while Neogen CorpNEOG's earnings per share (EPS) for the previous quarter was USD -0.08. EPS for the next quarter is expected at USD -0.07.
What is the analyst rating for Neogen Corp?
Based on the ratings of Neogen Corp's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.